Oncotelic

📍 Agoura Hills, United States👥 21 employees💰 Last funded Feb 2021
Biotechnology Research🌐 oncotelic.com
Website LinkedIn
Oncotelic /Mateon is a convergent of PointR AI clustercomputing, Oncotelic antisense platform, and Mateon vascular disrupting agent. Lead asset OT-101 is an antisense against TGF-beta for cancer, covid-19, and other viruses
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Oncotelic?
Oncotelic has 1 investors on record on gritt.io.
When did Oncotelic last raise funding?
The most recent investment in Oncotelic recorded on gritt.io was in February 2021.
What industry is Oncotelic in?
Oncotelic operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Oncotelic based?
Oncotelic is headquartered in Agoura Hills, United States.